Back to Agenda
Session 9: DMC and Interim Analysis
Session Chair(s)
Chen YAO
Associate Director
Peking University Clinical Research Institute, China
Tony Guo
Executive Director, Head of Biometrics China
BeiGene, China
Speaker(s)
Practice of DMCs in clinical trials in China
Chen YAO
Peking University Clinical Research Institute, China
Associate Director
How adaptive trial designs can increase efficiency in drug development: A case
Huaqiong SHEN, MD, PhD
Jiangsu Hengrui Medicine Co., Ltd., China
Chief Medical Officer
William Wang, PhD
Merck & Co, Inc, United States
President
Jacqueline Law, PhD
Roche, China
Have an account?